Ad is loading...
DAGVX
Price
$50.39
Change
+$0.54 (+1.08%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

DAGVX vs VVIAX

Header iconDAGVX vs VVIAX Comparison
Open Charts DAGVX vs VVIAXBanner chart's image
BNY Mellon Dynamic Value Fund A
Price$50.39
Change+$0.54 (+1.08%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
DAGVX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DAGVX vs. VVIAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAGVX is a StrongBuy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. DAGVX (7.16B). VVIAX pays higher dividends than DAGVX: VVIAX (2.36) vs DAGVX (0.68). DAGVX was incepted earlier than VVIAX: DAGVX (29 years) vs VVIAX (24 years). DAGVX is a more actively managed with annual turnover of: 106.44 vs. VVIAX (10.00). DAGVX has a lower initial minimum investment than VVIAX: DAGVX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. DAGVX (21.45). VVIAX return over 5 years is better than : 53.09 vs. DAGVX (39.69).
DAGVXVVIAXDAGVX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years24 years-
Gain YTD22.66319.672115%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets7.16B184B4%
Annual Yield % from dividends0.682.3629%
Returns for 1 year21.4526.0982%
Returns for 3 years3.6024.7715%
Returns for 5 years39.6953.0975%
Returns for 10 years18.84112.2617%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics